Diclofenac induces basophil degranulation without increasing CD63 expression in sensitive patients

Clinical and Experimental Immunology

Volumn 147, Issue 1, 2007, Pages 99-105

  Malbran A ^a,b   Yeyati, E ^b   Rey, G L ^b   Galassi, N ^c  

^a Asma e Inmunologia Clinica   (Argentina)

^b HOSPITAL BRITÁNICO DE BUENOS AIRES   (Argentina)

^c ACADEMIA NACIONAL DE MEDICINA   (Argentina)

Author keywords

Allergy; Basophil; CD63; Exocytosis; NSAIDs

Indexed keywords

CD63 ANTIGEN; CYTOKINE ANTIBODY; DICLOFENAC; FORMYLMETHIONYLLEUCYLPHENYLALANINE; IMMUNOGLOBULIN E ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; TOLONIUM CHLORIDE;

ALLERGY; ANTIGEN EXPRESSION; ARTICLE; BASOPHIL DEGRANULATION; CELL ACTIVATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DERMATOPHAGOIDES PTERONYSSINUS; DRUG HYPERSENSITIVITY; EXOCYTOSIS; FLOW CYTOMETRY; HUMAN; IN VITRO STUDY; MICROSCOPY; MITE; MONONUCLEAR CELL; PRIORITY JOURNAL; SYMPTOMATOLOGY;

ALLERGENS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIGENS, CD; BASOPHIL DEGRANULATION TEST; BASOPHILS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DERMATOPHAGOIDES PTERONYSSINUS; DICLOFENAC; DRUG HYPERSENSITIVITY; FLOW CYTOMETRY; HUMANS; HYPERSENSITIVITY; IMMUNIZATION; IMMUNOGLOBULIN E; PLATELET MEMBRANE GLYCOPROTEINS; SENSITIVITY AND SPECIFICITY;

EID: 33845483194     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.03265.x     Document Type: Article

References (31)

1. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279:1200-5.
2. Pirmohamed M, James S, Meakin S et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004; 329:15-9.
3. Monneret G, Benoit Y, Debard AL, Gutowski MC, Topenot I, Bienvenu J.Monitoring of basophil activation using CD63 and CCR3 in allergy to muscle relaxant drugs. Clin Immunol 2002; 102:192-9.
4. deShazo RD, Kemp SF. Allergic reaction to drugs and biological agents. JAMA 1997; 278:1896-906.
5. Shepherd GM. Hypersensitivity reactions to drugs: evaluation and management. Mt Sinai J Med 2003; 70:113-25.
6. Szczeklik A, Stevenson DD. Aspirin induced asthma: advances in pathogenesis and management. J Allergy Clin Immunol 1999; 104:5-13.
7. Szczeklik A, Stevenson DD. Aspirin induced asthma: advances in pathogenesis, diagnosis and management. J Allergy Clin Immunol 2003; 111:913-21.
8. Stevenson DD. Approach to the patient with a history of adverse reactions to aspirin or NSAIDs: diagnosis and treatment. Allergy Asthma Proc 2000; 21:25-31.
9. Benveniste J. The human basophil degranulation test as an in vitro method of diagnosis of allergies. Clin Allergy 1981; 11:1-11.
10. Demoly P, Lebel B, Messaad D et al. Predictive capacity of histamine release for the diagnosis of drug allergy. Allergy 1999; 54:500-6.
11. Lebel B, Messaad D, Kvedariene V, Rongier M, Bousquet J, Demoly P. Cysteinyl-leukotriene release test (CAST) in the diagnosis of immediate drug reactions. Allergy 2001; 56:688-92.
12. Hirsch SR, Zastrow JE. Basophil degranulation: a new method of observation and its correlation with skin testing. J Allergy Clin Immunol 1972; 50:338-47.
13. Gane P, Pecquet C, Crespeau H, Lambin P, Leynadier F, Rouger P. Flow cytometric monitoring of allergen induced basophil activation. Cytometry 1995; 19:361-5.
14. Monneret G, Gutowski MC, Bienvenu J. Detection of allergen-induced basophil activation by expression of CD63 antigen using a tricolour flow cytometric method. Clin Exp Immunol 1999; 115:393-6.
15. Boumiza R, Debard AL, Monneret G. The basophil activation test by flow cytometry: recent developments in clinical studies, standardization and emerging perspectives. Clin Mol Allergy 2005; 3:9.
16. Sturm GJ, Bohm E, Trummer M, Weiglhofer I, Heinemann A, Aberer W. The CD63 basophil activation test in Hymenoptera venom allergy: a prospective study. Allergy 2004; 59:1110-17.
17. Abuaf N, Rajoely B, Ghazouani E et al. Validation of flow cytometric assay detecting in vitro basophil activation for the diagnosis of muscle relaxant allergy. J Allergy Clin Immunol 1999; 104:411-8.
18. Pâris-Köhler A, Demoly P, Persi L, Lebel B, Bousquet J, Arnoux B. In vitro diagnosis of cypress pollen allergy by using cytofluorimetric analysis of basophils (Basotest). J Allergy Clin Immunol 2000; 105:339-45.
19. Cozon GJN, Ferrandiz J, Peyramond D, Brunet JL. Detection of activated basophils using flow cytometry for diagnosis in atopic patients. Allergol Immunopathol 1999; 27:182-7.
20. Sainte-Laudy J, Sabbah A, Vakllon C, Guérin JC. Analysis of anti IgE and allergen induced human basophil activation by flow cytometry. Comparison with histamine release. Inflamm Res 1998; 47:401-8.
21. Monneret-Vautrin DA, Sainte Laudy J, Kanny J, Fremont S. Human basophil activation measured by CD63 expression and LTC4 release in IgE mediated food allergy. Ann Allergy Asthma Immunol 1999; 82:33-40.
22. Goodman & Gilman's The pharmacological basis of therapeutics, 9th edn. Joel G Hardman, Lee L Limbird, Perry B Molinoff, Raymond W Ruddon and Alfred Goodman Gliman, eds. McGraw Hill Interamericana, Mexico 1996; 1:683-4.
23. Malbrán A, Riera NE, Rey G, de Bracco MM, Galassi NV. Studies of count and activation of basophils by flow cymetry and their application to diagnosis of immediate hypersensitivity disease. Arch Alergia Inmunol Clin 2003; 34:47-53.
24. Galassi N, Riera N, Rey G, Bracco MME, Malbrán A. Chronic urticaria. Clinical evolution, autologous serumtest, count and activation of basophils. Medicina (B. Aires) 2003; 63:15-20.
25. Gamboa P, Sanz ML, Caballero MR et al. The flow-cytometric determination of basophil activation induced by aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is useful for in vitro diagnosis of the NSAID hypersensitivity syndrome. Clin Exp Allergy 2004; 34:1448-57.
26. Kepley C, Youssef L, Andrews R, Wilson B, Oliver J. Syk deficiency in nonreleaser basophils. J Allergy Clin Immunol 1999; 104:279-84.
27. Knol E, Koenderman L, Mul F, Verhoeven A, Ross D. Differential activation of human basophils by anti-IgE and formyl-methionylleucyl-phenylalanine. Indications for protein kinase C-dependent and -independent activation pathways. Eur J Immunol 1991; 21:881-5.
28. Crivellato E, Nico B, Mallardi F, Beltrami CA, Ribatti D. Piecemeal degranulation as a general secretory mechanism? Anat Rec Part A 2003; 274:778-84.
29. Logan MR, Odemuyiwa SO, Moqbel R. Understanding exocytosis in immune and inflammatory cells: the molecular basis of mediator secretion. J Allergy Clin Immunol 2003; 111:923-32.
30. Dvorak AM, MacGlashan DW, Morgan ES, Lichtenstein LM. Histamine distribution in human basophil secretory granules undergoing fMLP-stimulated secretion and recovery. Blood 1995; 86:3560-6.
31. Dvorak AM, MacGlashan DW, Morgan ES, Lichtenstein LM. Vesicular transport of histamine in stimulated human basophils. Blood 1996; 88:4090-101.